GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Curocell Inc (XKRX:372320) » Definitions » Other Financing

Curocell (XKRX:372320) Other Financing : ₩0.00 Mil (TTM As of Jun. 2023)


View and export this data going back to 2023. Start your Free Trial

What is Curocell Other Financing?

Curocell's Other Financing for the six months ended in Jun. 2023 was ₩0.00 Mil.

Curocell's Other Financing for the trailing twelve months (TTM) ended in Jun. 2023 was ₩0.00 Mil.


Curocell Other Financing Historical Data

The historical data trend for Curocell's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Curocell Other Financing Chart

Curocell Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Other Financing
- - -18.17 - -

Curocell Semi-Annual Data
Jun22 Dec22 Jun23 Dec23
Other Financing - - - -

Curocell Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₩0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Curocell Other Financing Related Terms

Thank you for viewing the detailed overview of Curocell's Other Financing provided by GuruFocus.com. Please click on the following links to see related term pages.


Curocell (XKRX:372320) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
11, Gukjegwahak 16-ro, Yuseong-gu, Daejeon, KOR, 34002
Curocell Inc is engaged in medical and pharmaceutical research and development. The company is into development of CAR-T treatments that enhance the natural function of immune cells to eliminate cancer cells through genetic manipulation of human immune cells.

Curocell (XKRX:372320) Headlines

No Headlines